|
Product Details
| Unit Price |
|
$195.00
|
|
| Your Price |
$195.00
|
|
| Cat# |
34-7-12A |
|
| Sequence |
DPhe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2
|
|
| Unit |
|
|
| Weight |
0.5
mg
|
|
| MW |
3650.3 |
|
| CAS |
[220673-95-0] |
|
| Formula |
C161H274N48O46S
|
|
| Disulfide Bridge |
|
|
| References
Brauns, O., et al., Secondary structure of antisauvagine analogues is important for CRF receptor antagonism: development of antagonists with increased potency and receptor selectivity. Peptides 23, 1817-27, (2002). Wang, L., et al., Peripheral urocortin inhibits gastric emptying and food intake in mice: differential role of CRF receptor 2. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, 1401-10, (2001). Takahashi, L.K., et al., Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 902, 135-42, (2001). Higelin, J., et al., 125I-Antisauvagine-30: a novel and specific high-affinity radioligand for the characterization of corticotropin-releasing factor type 2 receptors. Neuropharmacology 40, 114-22, (2001).
|
Antisauvagine-30
|
|
|